Pulmonx Financial Statements From 2010 to 2026

LUNG Stock  USD 1.73  0.03  1.70%   
Pulmonx Corp's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pulmonx Corp's valuation are provided below:
Gross Profit
67.2 M
Profit Margin
(0.62)
Market Capitalization
72.6 M
Enterprise Value Revenue
0.5694
Revenue
91.7 M
There are over one hundred nineteen available trending fundamental ratios for Pulmonx Corp, which can be analyzed over time and compared to other ratios. Active traders should verify all of Pulmonx Corp recent fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The current Market Cap is estimated to decrease to about 529 M. Enterprise Value is estimated to decrease to about 482.9 M

Pulmonx Corp Total Revenue

101.18 Million

Check Pulmonx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmonx Corp's main balance sheet or income statement drivers, such as Interest Expense of 4.2 M, Selling General Administrative of 113.8 M or Total Revenue of 101.2 M, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0 or PTB Ratio of 1.58. Pulmonx financial statements analysis is a perfect complement when working with Pulmonx Corp Valuation or Volatility modules.
  
Build AI portfolio with Pulmonx Stock
Check out the analysis of Pulmonx Corp Correlation against competitors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Pulmonx Corp Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets101.3 M187.3 M82 M
Slightly volatile
Total Current Liabilities29.5 M28.1 M10.7 M
Slightly volatile
Accounts Payable4.6 M4.4 M1.5 M
Slightly volatile
Cash60.2 M81.5 M47 M
Slightly volatile
Long Term Debt41.1 M39.1 M15.4 M
Slightly volatile
Inventory20.4 M19.5 M7.7 M
Slightly volatile
Total Liabilities63.4 M88.6 M49.9 M
Slightly volatile
Short and Long Term Debt3.8 M3.7 M1.2 M
Slightly volatile
Total Current Assets88.7 M156.7 M71.4 M
Slightly volatile
Short Term Debt4.8 M4.5 M2.1 M
Slightly volatile
Common Stock26.6 K46 K24.2 K
Slightly volatile
Property Plant Equipment4.1 M6.1 M3.4 M
Slightly volatile
Net Receivables16.7 M15.9 M5.9 M
Slightly volatile
Other Assets1.091.15673.7 K
Pretty Stable
Other Current Assets4.9 M4.7 M1.8 M
Slightly volatile
Intangible Assets26.5 K27.9 K205.4 K
Pretty Stable
Short and Long Term Debt Total49.9 M50.8 M47.4 M
Pretty Stable
Other Current Liabilities12.8 M18 M9.4 M
Slightly volatile
Other Liabilities58.1 K84.6 K100.6 K
Slightly volatile
Property Plant And Equipment Net25.9 M24.7 M7.3 M
Slightly volatile
Current Deferred Revenue103.4 K121.5 K131.9 K
Slightly volatile
Non Current Assets Total21.3 M30.6 M12.8 M
Slightly volatile
Non Currrent Assets Other2.4 M3.2 M1.4 M
Slightly volatile
Cash And Short Term Investments126.3 M116.7 M63.5 M
Slightly volatile
Good Will1.9 M2.1 M2.3 M
Slightly volatile
Common Stock Total Equity32.3 K43.7 K25.6 K
Slightly volatile
Common Stock Shares Outstanding38.1 M45 M28.9 M
Slightly volatile
Liabilities And Stockholders Equity173.1 M187.3 M93.1 M
Slightly volatile
Non Current Liabilities Total64.1 M47.3 M121.5 M
Slightly volatile
Other Stockholder Equity404.4 M633.9 M222.4 M
Slightly volatile
Property Plant And Equipment Gross32.8 M31.3 M7.9 M
Slightly volatile
Accumulated Other Comprehensive IncomeM2.4 M1.6 M
Slightly volatile
Capital Stock35.5 K46 K26.1 K
Slightly volatile
Net Working Capital133.2 M128.6 M66.8 M
Slightly volatile
Deferred Long Term Liabilities80.4 K84.6 K951.5 K
Slightly volatile
Long Term Debt Total658.9 K729.1 K595.8 K
Slightly volatile
Capital Surpluse532.7 M578.1 M484.7 M
Slightly volatile
Non Current Liabilities Other12.2 M19 M21.4 M
Slightly volatile

Pulmonx Corp Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative113.8 M108.4 M38.5 M
Slightly volatile
Research Development21.2 M20.2 M7.9 M
Slightly volatile
Tax Provision369.8 K575 K199.6 K
Slightly volatile
Interest Income6.1 M5.8 M1.4 M
Slightly volatile
Depreciation And Amortization1.2 M1.8 M765.2 K
Slightly volatile
Selling And Marketing Expenses9.5 M9.1 M2.7 M
Slightly volatile
Other Operating Expenses99.1 M162.7 M69 M
Slightly volatile
Reconciled DepreciationM1.7 M679.9 K
Slightly volatile

Pulmonx Corp Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
DepreciationM1.7 M834.3 K
Slightly volatile
Capital Expenditures868.4 K1.7 M706.4 K
Slightly volatile
Total Cash From Financing Activities1.5 M1.6 M20 M
Pretty Stable
Change To Netincome20.6 M19.6 M6.6 M
Slightly volatile
End Period Cash Flow91.6 M81.8 M53.5 M
Slightly volatile
Stock Based Compensation27.7 M26.4 M7.8 M
Slightly volatile
Begin Period Cash Flow93.5 M96.4 M50.9 M
Slightly volatile
Other Cashflows From Financing Activities1.2 M1.3 M3.2 M
Pretty Stable
Other Non Cash Items2.3 M2.4 M2.4 M
Slightly volatile
Dividends Paid18 M19.3 M34.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.463.6431.2542
Slightly volatile
Days Sales Outstanding48.5854.0760.4187
Slightly volatile
Stock Based Compensation To Revenue0.260.250.119
Slightly volatile
Capex To Depreciation1.251.111.1608
Pretty Stable
EV To Sales3.273.4531.7485
Slightly volatile
Inventory Turnover1.461.481.8142
Slightly volatile
Days Of Inventory On Hand248255231
Slightly volatile
Payables Turnover5.865.126.4762
Pretty Stable
Sales General And Administrative To Revenue0.941.011.0909
Slightly volatile
Research And Ddevelopement To Revenue0.290.240.3011
Slightly volatile
Capex To Revenue0.03070.01990.0219
Slightly volatile
Cash Per Share2.512.341.6707
Slightly volatile
Days Payables Outstanding61.2873.7359.566
Pretty Stable
Income Quality0.90.640.8969
Slightly volatile
Intangibles To Total Assets0.01570.01650.1138
Slightly volatile
Current Ratio6.555.024.7115
Slightly volatile
Receivables Turnover6.696.996.0608
Slightly volatile
Capex Per Share0.02930.03330.026
Slightly volatile
Revenue Per Share1.091.931.1934
Slightly volatile
Interest Debt Per Share2.081.761.8247
Very volatile
Debt To Assets0.380.41.5347
Slightly volatile
Operating Cycle297309292
Slightly volatile
Days Of Payables Outstanding61.2873.7359.566
Pretty Stable
Ebt Per Ebit1.161.111.1414
Slightly volatile
Quick Ratio6.04.394.1664
Slightly volatile
Net Income Per E B T0.810.910.9872
Slightly volatile
Cash Ratio6.373.343.1957
Slightly volatile
Cash Conversion Cycle252251234
Slightly volatile
Days Of Inventory Outstanding248255231
Slightly volatile
Days Of Sales Outstanding48.5854.0760.4187
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.830.941.0102
Slightly volatile
Fixed Asset Turnover4.274.4930.4922
Slightly volatile
Debt Ratio0.380.41.5347
Slightly volatile
Price Sales Ratio3.463.6431.2542
Slightly volatile
Asset Turnover0.540.590.8964
Slightly volatile
Gross Profit Margin0.560.670.65
Slightly volatile

Pulmonx Corp Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap529 M556.8 M865.2 M
Pretty Stable
Enterprise Value482.9 M508.4 M859 M
Pretty Stable

Pulmonx Fundamental Market Drivers

Forward Price Earnings28.3286
Cash And Short Term Investments101.5 M

Pulmonx Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pulmonx Corp Financial Statements

Pulmonx Corp stakeholders use historical fundamental indicators, such as Pulmonx Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pulmonx Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulmonx Corp's assets and liabilities are reflected in the revenues and expenses on Pulmonx Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulmonx Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue121.5 K103.4 K
Total Revenue96.4 M101.2 M
Cost Of Revenue25.1 M26.3 M
Stock Based Compensation To Revenue 0.25  0.26 
Sales General And Administrative To Revenue 1.01  0.94 
Research And Ddevelopement To Revenue 0.24  0.29 
Capex To Revenue 0.02  0.03 
Revenue Per Share 1.93  1.09 
Ebit Per Revenue(0.79)(0.83)

Currently Active Assets on Macroaxis

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out the analysis of Pulmonx Corp Correlation against competitors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Pulmonx have expansion opportunities? Factors like these will boost the valuation of Pulmonx Corp. Expected growth trajectory for Pulmonx significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Pulmonx Corp demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(1.41)
Revenue Per Share
2.279
Quarterly Revenue Growth
0.055
Return On Assets
(0.23)
Return On Equity
(0.74)
Understanding Pulmonx Corp requires distinguishing between market price and book value, where the latter reflects Pulmonx's accounting equity. The concept of intrinsic value—what Pulmonx Corp's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Pulmonx Corp's price substantially above or below its fundamental value.
Understanding that Pulmonx Corp's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Pulmonx Corp represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Pulmonx Corp's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.